SCHEMBL28648284

SCHEMBL28648284

CC(C)(C)OC(=O)NCC1CCN(c2ccc(F)cc2C=O)C1

nearest known ligand 0.45

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CKS1B P61024 1/20 0.45
▸ SKP1 P63208 1/20 0.45
▸ SKP2 Q13309 1/20 0.45
▸ ACACB O00763 7/20 0.44
▸ ACACA Q13085 7/20 0.44
▸ DRD2 P14416 2/20 0.43
▸ SUV39H2 Q9H5I1 1/20 0.43
▸ RPS6KB1 P23443 2/20 0.42
▸ NAMPT P43490 1/20 0.41
▸ EEF2K O00418 1/20 0.41
▸ IRAK1 P51617 1/20 0.40
▸ BRD3 Q15059 1/20 0.39
▸ RORC P51449 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28926895 0.95 CKS1B (0.49) CKS1BSKP1SKP2ACACBACACA
SCHEMBL25080904 0.88 ACACB (0.47) CKS1BSKP1SKP2ACACBACACA
SCHEMBL12284231 0.85 SUV39H2 (0.48) CKS1BSKP1SKP2ACACBACACA
SCHEMBL28647151 0.82 DRD2 (0.38) CKS1BSKP1SKP2ACACBACACA
SCHEMBL8214675 0.82 CKS1B (0.49) CKS1BSKP1SKP2ACACBACACA
SCHEMBL4288052 0.82 ACACB (0.47) CKS1BSKP1SKP2ACACBACACA
SCHEMBL4288054 0.82 ACACB (0.47) CKS1BSKP1SKP2ACACBACACA
SCHEMBL16896516 0.81 CKS1B (0.51) CKS1BSKP1SKP2ACACBACACA
SCHEMBL7093978 0.81 CKS1B (0.52) CKS1BSKP1SKP2ACACBACACA
SCHEMBL16896437 0.80 CKS1B (0.48) CKS1BSKP1SKP2ACACBACACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113527298-B Macrocyclic lactam derivatives, preparation method and application thereof 浙江海正药业股份有限公司 2025-01-03 — — CN disclosed
CN-113527298-A Macrocyclic lactam derivative, preparation method and application thereof 浙江海正药业股份有限公司 2021-10-22 — — CN disclosed
Send feedback